Davison Grant Genetics Company Story - This is Who We Are

A Need in the Human Condition:

It’s rare that a highly successful company mirrors its original business model more than 15 years later. Amazingly, the vision and insight into an unfulfilled consumer need which Dr. Rainier R. Davison (a former high-level government scientist) developed in 1997 in the warehouse district in Mannheim, Germany is still being realized at Davison Grant Genetics, the leading provider of genetically manufactured products and treatments to the human race around the globe. Dr. Davison, the President, Chairman, Senior Research Scientist, CEO, Chief of Staff, Head of the Department of Innovation, Improvement and Evolution (DIIE) and founder of the company, originally cited a need in the genetic marketplace in 1995. He noted that no other vendor or sanctioned government agency had met the need for customized genetic products and remedies for people of means wanting to enhance every aspect of their carbon-based lives. At the time, individuals seeking genetic enhancement and modification were forced to seek treatments through illegal means or to simply go without them, due to exorbitant costs. The dream to live longer, be healthier and appear more beautiful has been the company’s declaration throughout its evolution, and one that arguably has relevance to every human being on the planet.


Conceived and written with Dr. Davison’s long-time associate and friend, Dr. Joseph C. Grant, the first page of the company’s 1997 business plan summarized Davison Grant Genetic’s mission in this way: “You are a human being with aspirations of greatness and perfection... You know your life has value… You want to improve yourself, help cultivate a flawless culture and build an aesthetically pleasing environment. The scientific market today does not provide a final solution to meet these needs. Everyone knows that the terms ‘refinement,’ ‘immortality,’ ‘beauty’ and ‘evolutionary design’ simply don’t belong in the same sentence with ‘affordable,’ ‘obtainable,’ ‘easy’ or ‘quick.’ This incompatibility represents a gap in the market. Simply put, there is a clear market need.”


Started in a large repository with substantial funds from private investors, Davison Grant Genetics began to evolve into a powerhouse company by 1999. A big breakthrough came in 2000, when the company developed major innovations in hybrid life-forms, cloning, pharmaceuticals and Transhumanist production methods that were light-years ahead of any university-based research facility. Not having to deal with the same legal or social issues hampering all state and federally funded establishments, Dr. Davison and Dr. Grant were able to freely navigate a bold scientific frontier aimed at eliminating mankind’s frailties and imperfections. Along the way, they were additionally able to develop advances of purely aesthetic concerns to the human race.


Eliminate the Weak:

Using patented technology and gene therapies, known as “Allele Expressionism,” the company produced a run of high earnings in the financial market in a rapid fashion. This crippled many university-related research discoveries and allowed Davison Grant Genetics to flourish and begin offering their discoveries to the general public. Their initial line of pharmaceutical products was first launched in October of 2002 and almost immediately skyrocketed the company to a multi-billion dollar business. Few could have predicted a global financial crash in 2008 that would bring many companies to the brink of bankruptcy. Not surprisingly, Davison Grant Genetics has weathered all the major economic storms over the past 15 years and has posted major profits for its shareholders. With this financial growth motivating the head office, Davison Grant Genetics has steadily evolved into a major scientific industrial complex, determined to become the world’s leader in a variety of life-improving products relating to the field of genetics. For the greater good, their mission is to literally have an effect on every living cell on earth.


Expansion, Growth and the Future:

Since 2005, Davison Grant Genetics has consistently seen double-digit growth rates while expanding into global markets like China, Saudi Arabia, Brazil and Australia. The company has also grown beyond just a genetic laboratory and is now offering a myriad of lifestyle solutions. Today, the company has over 12,000 employees, nine state-of-the-art research laboratory facilities and 23 offices, including its corporate headquarters in Berlin, Germany. In 2011, Davison Grant Genetics broke ground on a new multi-billion-dollar facility in Amsterdam, the Netherlands. Monitored 24 hours a day by the world’s most sophisticated security systems, this facility is where the company will perform all of their future top secret experiments and store vital materials relating to technological explorations in the realm of bioscience. With the target date for its grand opening set for December, 2015, the top genetic scientists from around the world will soon be able to perform advanced experiments free from most political and sanctimonious constraints.


Add the Best:

Over the years, Davison Grant Genetics has given millions of people from around the world the opportunity to make inconceivable improvements in their lives and the chance to swiftly advance their evolutionary timelines. With commercial demand fueled by the clearly voiced insistence of the general public to rapidly improve the quality of life, this visionary company is taking a strong leadership role in genetic discoveries with sincere earnest and with great hopes of ushering in a utopian world.

Davison Grant Genetics
BIOGENETICS
The code to the future is here!main.html

© 2015 All Rights Reserved. Davison Grant Genetics, INC.

Davison Grant Genetics
BIOGENETICS
The code to the future is here!main.html

Davison Grant Genetics

1227 Wernersteinlawn Dr.

Mannheim, Germany 09669-312

dggenetics@dgg.gr.com